Patents by Inventor Xunshan Ding

Xunshan Ding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of lowering triglyceride levels with an ANGPTL8-binding antibody or antigen-binding fragment thereof
    Patent number: 11566067
    Abstract: The present disclosure provides binding agents, such as antibodies, that specifically bind Angiopoietin-like protein 8 (ANGPTL8), including human ANGPTL8, and methods of their use.
    Type: Grant
    Filed: August 18, 2020
    Date of Patent: January 31, 2023
    Assignee: NGM Biopharmaceuticals, Inc.
    Inventors: Chun Chu, Xunshan Ding, Zhonghao Liu, Yan Wang, Yiyuan Yin, Wenwu Zhai
  • ANGPTL8-BINDING AGENTS AND METHODS OF USE THEREOF
    Publication number: 20210095014
    Abstract: The present disclosure provides binding agents, such as antibodies, that specifically bind Angiopoietin-like protein 8 (ANGPTL8), including human ANGPTL8, and methods of their use.
    Type: Application
    Filed: August 18, 2020
    Publication date: April 1, 2021
    Inventors: Chun Chu, Xunshan Ding, Zhonghao Liu, Yan Wang, Yiyuan Yin, Wenwu Zhai
  • ANGIOPOIETIN-LIKE PROTEIN 8 POLYPEPTIDE FRAGMENTS AND COMPOSITIONS THEREOF
    Publication number: 20210015902
    Abstract: Methods and compositions for reducing one or more of triglyceride levels, total cholesterol levels and LDL cholesterol levels in a subject are provided. The methods include administering a fragment of ANGPTL8 to a subject having or at risk of developing elevated triglyceride levels, elevated total cholesterol levels and/or elevated LDL cholesterol levels.
    Type: Application
    Filed: May 29, 2020
    Publication date: January 21, 2021
    Inventors: Zhonghao Liu, Xunshan Ding
  • ANGPTL8-binding agents and methods of use thereof
    Patent number: 10774139
    Abstract: The present disclosure provides binding agents, such as antibodies, that specifically bind Angiopoietin-like protein 8 (ANGPTL8), including human ANGPTL8, and methods of their use.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: September 15, 2020
    Assignee: NGM Biopharmaceuticals, Inc.
    Inventors: Chun Chu, Xunshan Ding, Zhonghao Liu, Yan Wang, Yiyuan Yin, Wenwu Zhai
  • Angiopoietin-like protein 8 polypeptide fragments and compositions thereof
    Patent number: 10702587
    Abstract: Methods and compositions for reducing one or more of triglyceride levels, total cholesterol levels and LDL cholesterol levels in a subject are provided. The methods include administering a fragment of ANGPTL8 to a subject having or at risk of developing elevated triglyceride levels, elevated total cholesterol levels and/or elevated LDL cholesterol levels.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: July 7, 2020
    Assignee: NGM Biopharmaceuticals, Inc.
    Inventors: Zhonghao Liu, Xunshan Ding
  • ANGPTL8-BINDING AGENTS AND METHODS OF USE THEREOF
    Publication number: 20190169281
    Abstract: The present disclosure provides binding agents, such as antibodies, that specifically bind Angiopoietin-like protein 8 (ANGPTL8), including human ANGPTL8, and methods of their use.
    Type: Application
    Filed: November 8, 2018
    Publication date: June 6, 2019
    Inventors: Chun Chu, Xunshan Ding, Zhonghao Liu, Yan Wang, Yiyuan Yin, Wenwu Zhai
  • METHODS AND COMPOSITIONS FOR TREATMENT OF CONDITIONS ASSOCIATED WITH ELEVATED TRIGLYCERIDES
    Publication number: 20190060408
    Abstract: Methods and compositions for reducing one or more of triglyceride levels, total cholesterol levels and LDL cholesterol levels in a subject are provided. The methods include administering a fragment of ANGPTL8 to a subject having or at risk of developing elevated triglyceride levels, elevated total cholesterol levels and/or elevated LDL cholesterol levels.
    Type: Application
    Filed: August 6, 2018
    Publication date: February 28, 2019
    Inventors: Zhonghao Liu, Xunshan Ding
  • Methods for treatment of conditions associated with elevated triglycerides with an ANGPTL8 polypeptide fragment
    Patent number: 10071139
    Abstract: Methods and compositions for reducing one or more of triglyceride levels, total cholesterol levels and LDL cholesterol levels in a subject are provided. The methods include administering a fragment of ANGPTL8 to a subject having or at risk of developing elevated triglyceride levels, elevated total cholesterol levels and/or elevated LDL cholesterol levels.
    Type: Grant
    Filed: October 2, 2015
    Date of Patent: September 11, 2018
    Assignee: NGM Biopharmaceuticals, Inc.
    Inventors: Zhonghao Liu, Xunshan Ding
  • Methods and Compositions for Treatment of Conditions Associated with Elevated Triglycerides
    Publication number: 20170143799
    Abstract: Methods and compositions for reducing one or more of triglyceride levels, total cholesterol levels and LDL cholesterol levels in a subject are provided. The methods include administering a fragment of ANGPTL8 to a subject having or at risk of developing elevated triglyceride levels, elevated total cholesterol levels and/or elevated LDL cholesterol levels.
    Type: Application
    Filed: October 2, 2015
    Publication date: May 25, 2017
    Inventors: Zhonghao Liu, Xunshan Ding